Skip to main navigation Skip to search Skip to main content

Association of Differential Mast Cell Activation with Granulocytic Inflammation in Severe Asthma

  • U-BIOPRED Consortium Project Team
  • National Heart and Lung Institute and
  • CHU de Nancy
  • Imperial College London
  • Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland
  • Institute of Environmental Medicine and
  • Karolinska Institutet
  • University of Technology Sydney
  • University of Southampton
  • 1st Department of Cardiology, Interventional Electrocardiology and Hypertension, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland
  • Karolinska University Hospital
  • University of Amsterdam
  • Royal Brompton and Harefield NHS Trust
  • Johnson and Johnson Pharmaceutical Research and Development
  • GlaxoSmithKline
  • AstraZeneca Sweden
  • University Hospital Southampton NHS Foundation Trust
  • Université de Lyon
  • Acclarogen
  • Knowles Consulting
  • Boehringer Ingelheim GmbH
  • BioSci Consulting
  • Fraunhofer Institute for Toxicology and Experimental Medicine
  • Chiesi Pharmaceutics Ltd.
  • Genentech Incorporated
  • Novartis
  • Merck
  • ELF
  • University of Catania
  • Centre Hospitalo-Universitaire Timone
  • Semmelweis University
  • Umeå University

Research output: Contribution to journalArticleAcademicpeer-review

73 Downloads (Pure)

Abstract

Rationale: Mast cells (MCs) play a role in inflammation and both innate and adaptive immunity, but their involvement in severe asthma (SA) remains undefined. Objectives: We investigated the phenotypic characteristics of the U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Diseases Outcomes) asthma cohort by applying published MC activation signatures to the sputum cell transcriptome. Methods: Eighty-four participants with SA, 20 with mild/moderate asthma (MMA), and 16 healthy participants without asthma were studied. We calculated enrichment scores (ESs) for nine MC activation signatures by asthma severity, sputum granulocyte status, and three previously defined sputum molecular phenotypes or transcriptome-associated clusters (TACs) 1, 2, and 3 using gene set variation analysis. Measurements and Main Results: MC signatures except unstimulated, repeated FceR1-stimulated and IFN-g–stimulated signatures were enriched in SA. A FceR1-IgE–stimulated and a single-cell signature from asthmatic bronchial biopsies were highly enriched in eosinophilic asthma and in the TAC1 molecular phenotype. Subjects with a high ES for these signatures had elevated sputum amounts of similar genes and pathways. IL-33– and LPS-stimulated MC signatures had greater ES in neutrophilic and mixed granulocytic asthma and in the TAC2 molecular phenotype. These subjects exhibited neutrophil, NF-kB (nuclear factor-kB), and IL-1b/TNF-a (tumor necrosis factor-a) pathway activation. The IFN-g–stimulated signature had the greatest ES in TAC2 and TAC3 that was associated with responses to viral infection. Similar results were obtained in an independent ADEPT (Airway Disease Endotyping for Personalized Therapeutics) asthma cohort. Conclusions: Gene signatures of MC activation allow the detection of SA phenotypes and indicate that MCs can be induced to take on distinct transcriptional phenotypes associated with specific clinical phenotypes. IL-33–stimulated MC signature was associated with severe neutrophilic asthma, whereas IgE-activated MC was associated with an eosinophilic phenotype.

Original languageEnglish
Pages (from-to)397-411
Number of pages15
JournalAmerican journal of respiratory and critical care medicine
Volume205
Issue number4
Early online dateNov 2021
DOIs
Publication statusPublished - 15 Feb 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Eosinophils
  • IL-33
  • IgE-FceRI
  • Mast cell
  • Neutrophils

Fingerprint

Dive into the research topics of 'Association of Differential Mast Cell Activation with Granulocytic Inflammation in Severe Asthma'. Together they form a unique fingerprint.

Cite this